{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:13:57Z","timestamp":1783696437431,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2113-M-002-010-MY3"],"award-info":[{"award-number":["113-2113-M-002-010-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clnu.2026.106664","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:50:10Z","timestamp":1776383410000},"page":"106664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipidomic profiling of plasma triglyceride species reveals distinct signatures and dietary associations in drug-refractory hypertriglyceridemia"],"prefix":"10.1016","volume":"61","author":[{"given":"Chih-Ning","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chieh","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Lung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siao-Jyuan","family":"Jhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin Elizabeth","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Chen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-0360","authenticated-orcid":false,"given":"Ching-Hua","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2026.106664_bib1","first-page":"242","article-title":"Prevalence of hypertriglyceridemia in adults and related cardiometabolic factors. SIMETAP-HTG study","volume":"32","author":"Ruiz-Garc\u00eda","year":"2020","journal-title":"Cl\u00edn Invest Arterioscler"},{"key":"10.1016\/j.clnu.2026.106664_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ejim.2014.08.008","article-title":"Current knowledge of hypertriglyceridemic pancreatitis","volume":"25","author":"Valdivielso","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clnu.2026.106664_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","article-title":"Hypertriglyceridaemia and risk of coronary artery disease","volume":"14","author":"Reiner","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.clnu.2026.106664_bib4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American college of cardiology solution set oversight committee","volume":"78","author":"Virani","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clnu.2026.106664_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11789-012-0042-x","article-title":"Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis","volume":"7","author":"Ewald","year":"2012","journal-title":"Clin Res Cardiol Suppl"},{"key":"10.1016\/j.clnu.2026.106664_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia","volume":"272","author":"Surendran","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.clnu.2026.106664_bib7","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/FPC.0b013e328340095e","article-title":"Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics","volume":"20","author":"Brisson","year":"2010","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.clnu.2026.106664_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clnu.2026.106664_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jacl.2022.11.007","article-title":"The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants","volume":"17","author":"Perera","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.clnu.2026.106664_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jacl.2023.08.003","article-title":"Variability of longitudinal triglyceride phenotype in patients heterozygous for pathogenic APOA5 variants","volume":"17","author":"Perera","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.clnu.2026.106664_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10557-017-6737-y","article-title":"Plasma lipidome analysis by liquid chromatography-high resolution mass spectrometry and ion mobility of hypertriglyceridemic patients on extended-release nicotinic acid: a pilot study","volume":"31","author":"Ferchaud-Roucher","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.clnu.2026.106664_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012415","article-title":"Coronary artery disease risk and lipidomic profiles are similar in hyperlipidemias with family history and population-ascertained hyperlipidemias","volume":"8","author":"R\u00e4m\u00f6","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.clnu.2026.106664_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13020222","article-title":"Mass-spectrometry-based lipidomics discriminates specific changes in lipid classes in healthy and dyslipidemic adults","volume":"13","author":"S\u00e1nchez-Vinces","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.clnu.2026.106664_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/jdi.13924","volume":"14","author":"Taya","year":"2023","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.clnu.2026.106664_bib15","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2026.106664_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2025.343874","article-title":"Establishment of a pseudotargeted LC\u2012MS\/MS workflow for analyzing triglycerides in biological samples","volume":"1350","author":"Wang","year":"2025","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.clnu.2026.106664_bib17","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.jasms.2010.08.011","article-title":"Ozone-induced dissociation on a modified tandem linear ion-trap: observations of different reactivity for isomeric lipids","volume":"21","author":"Poad","year":"2010","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.clnu.2026.106664_bib18","series-title":"Artificial intelligence based LC-OzESI-MRM for isomer-resolved triacylglycerol profiling by In-Source ozonolysis","author":"Randolph","year":"2025"},{"key":"10.1016\/j.clnu.2026.106664_bib19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2018.08.022","article-title":"Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan","volume":"277","author":"Hsiung","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnu.2026.106664_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.clnu.2026.106664_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.clnu.2026.106664_bib22","first-page":"627","article-title":"Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation","volume":"4","author":"Hajian-Tilaki","year":"2013","journal-title":"Caspian J Intern Med"},{"key":"10.1016\/j.clnu.2026.106664_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate - a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc B Stat Methodol"},{"key":"10.1016\/j.clnu.2026.106664_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11883-021-00939-y","article-title":"The genetic basis of hypertriglyceridemia","volume":"23","author":"Carrasquilla","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.clnu.2026.106664_bib25","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jada.2009.05.027","article-title":"Ada. Position of the American dietetic association: vegetarian diets","volume":"109","author":"Craig","year":"2009","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.clnu.2026.106664_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ajcn\/77.1.43","article-title":"Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets","volume":"77","author":"Schwarz","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2026.106664_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/physrev.00024.2006","article-title":"Disordered lipid metabolism and the pathogenesis of insulin resistance","volume":"87","author":"Savage","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.clnu.2026.106664_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003102","article-title":"Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: a pooled analysis of prospective cohort studies","volume":"17","author":"Imamura","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.clnu.2026.106664_bib29","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1194\/jlr.R066514","article-title":"Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment","volume":"57","author":"Ertunc","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clnu.2026.106664_bib30","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/ajcn\/66.5.1072","article-title":"Dietary carbohydrates and insulin sensitivity: a review of the evidence and clinical implications","volume":"66","author":"Daly","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2026.106664_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.lfs.2018.04.049","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance - a review","volume":"203","author":"Saini","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.clnu.2026.106664_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plipres.2007.12.004","article-title":"The opposing effects of n-3 and n-6 fatty acids","volume":"47","author":"Schmitz","year":"2008","journal-title":"Prog Lipid Res"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426000919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426000919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:33:27Z","timestamp":1783694007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561426000919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":32,"alternative-id":["S0261561426000919"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106664","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipidomic profiling of plasma triglyceride species reveals distinct signatures and dietary associations in drug-refractory hypertriglyceridemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106664"}}